Yael Cohen

26PUBLICATIONS
95CO-AUTHORS
Haematological tumoursMedical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Sep 25, 2026
Daratumumab Plus Bortezomib, Lenalidomide, and Dexamethasone in Newly Diagnosed Multiple Myeloma: Transplant-Ineligible Subgroup Analysis of CEPHEUS.

|Sep 02, 2026
A single-cell atlas of multiple myeloma defines malignant archetypes and proliferative states.

|Feb 27, 2026
Surveillance of Smoldering Myeloma Patients Who Progress to Active Disease Is Associated with Favorable Outcomes.

Gil Fridberg, Inbar Cohen, Renana Robinson

|Dec 30, 2025
Extramedullary Disease-Achilles Heel in Myeloma?

Shaji Kumar, Joshua Richter, Saad Z Usmani

|Feb 05, 2025
Daratumumab plus bortezomib, lenalidomide and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: the randomized phase 3 CEPHEUS trial.

Saad Z Usmani, Thierry Facon, Vania Hungria

|Apr 06, 2023
Preclinical discovery and initial clinical data of WVT078, a BCMA × CD3 bispecific antibody.

Marc S Raab, Yael C Cohen, Fredrik Schjesvold

Pageof 5

Frequent Collaborators

6 joint publications

Irit Avivi

5 joint publications

Moshe Gatt

5 joint publications

Chezi Ganzel

4 joint publications

Nizar J Bahlis